Updated August 4, 2026

Vyvanse Cost in 2026: With Insurance, Without Insurance & Ways to Save

Evan Brown
Written by Evan Brown
Prescription Savings Researcher
Dr Megan Harris Medically Reviewed by Dr. Megan Harris, MD
Editorial Review: This guide explains what Vyvanse and generic lisdexamfetamine cost in 2026, how pricing differs with and without insurance, and every legitimate way to lower your out-of-pocket cost — from generics and discount cards to manufacturer savings programs and income-based patient assistance.
Quick Answer

Brand-name Vyvanse typically costs $400–$558 for a 30-day supply without insurance. Generic lisdexamfetamine, available since August 2023, is far cheaper — often $60–$85 a month with a free discount card, though full retail price without one can still run $300+. With commercial insurance, generic copays usually land between $10 and $35, while brand copays run higher, often $40–$100+, since most formularies now favor the generic.

Lowest realistic price: generic lisdexamfetamine with a GoodRx or SingleCare coupon. If uninsured and income-eligible: Takeda's Help at Hand program can provide brand Vyvanse at no cost.

$400–$558

Brand Vyvanse, no insurance
(30-day supply)

$60–$85

Generic lisdexamfetamine
with discount card

$0

Cost via Takeda Help at Hand
(if income-eligible)

Key Takeaways

  • Generic lisdexamfetamine, on the market since August 2023, is the single biggest way to cut your Vyvanse cost.
  • Cash price and insurance copay are two very different numbers — always check both before assuming what you'll pay.
  • Most commercial insurance and Medicare Part D plans prefer the generic and may require prior authorization or step therapy for brand Vyvanse.
  • Manufacturer savings cards only help if you have commercial insurance; uninsured patients need a different program.
  • Vyvanse has faced intermittent 2026 supply shortages — price and availability can both vary by pharmacy on a given week.

If you've just picked up a Vyvanse prescription and the pharmacy quoted you a price north of $400, you're not imagining things — and you're also not stuck paying it.

Vyvanse (lisdexamfetamine dimesylate) is one of the most commonly prescribed medications for ADHD and the only FDA-approved stimulant for binge eating disorder. For years, brand-name Vyvanse had no generic competition, and prices sat in the $350–$450 range for a 30-day supply. That changed in August 2023, when the FDA approved the first generic lisdexamfetamine. Prices for the generic dropped sharply, and today most patients have several realistic paths to a much lower bill.

This guide breaks down exactly what Vyvanse and generic lisdexamfetamine cost in 2026, how insurance changes the number, and which savings option actually fits your situation — whether you're commercially insured, on Medicare, or paying cash.

Why Vyvanse Costs What It Does

Three things drive Vyvanse's price: its status as a Schedule II controlled substance, its patented prodrug delivery system, and how insurance formularies have responded since generic competition arrived.

Factor Why It Matters for Price
Schedule II controlled substance Extra DEA manufacturing quotas and distribution requirements add cost throughout the supply chain
Prodrug technology Lisdexamfetamine is inactive until metabolized in red blood cells, a delivery mechanism Takeda originally patented
Generic entry (August 2023) Multiple manufacturers, including Teva and Alvogen, now produce generic lisdexamfetamine, which sharply lowered cash and insurance prices
Formulary tier placement Most insurers moved brand Vyvanse to a non-preferred or specialty tier while keeping generic lisdexamfetamine on a low, preferred tier

Why this matters: If your pharmacist fills your prescription as brand Vyvanse by default, you may be paying several times more than necessary. Ask specifically whether generic lisdexamfetamine is appropriate for your prescription.

Vyvanse Cost Without Insurance

Cash prices vary by dose, pharmacy, and whether you use a free discount card. Here's what to expect for a standard 30-day supply.

Vyvanse and lisdexamfetamine cash prices without insurance (2026)
Medication Retail Price (No Coupon) With GoodRx/SingleCare Coupon
Brand Vyvanse, 30mg capsules (30-day)$400–$558$387–$450
Generic lisdexamfetamine, 30mg (30-day)$300–$440$60–$85
Brand Vyvanse, higher strengths (50–70mg)$450–$600+$400–$520
Generic lisdexamfetamine, higher strengths$320–$460$65–$95

Retail price and coupon price are two different numbers. A pharmacy's default "cash price" for the generic can still be several hundred dollars if you don't present a discount card. Always ask the pharmacist to run a GoodRx, SingleCare, or Optum Perks coupon before paying the quoted price.

Vyvanse Cost With Insurance

Insurance dramatically changes the picture, but the amount still depends heavily on whether your plan prefers the brand or the generic, and where you are in your deductible.

Typical Vyvanse copays with commercial insurance (2026)
Scenario Typical Copay Range
Generic lisdexamfetamine, preferred tier$10–$35
Generic lisdexamfetamine, before deductible metFull negotiated price until deductible is met
Brand Vyvanse, non-preferred tier$40–$100+
Brand Vyvanse, without prior authorization on fileFull cash price until PA is approved

Prior authorization is common for brand Vyvanse. Many plans require documentation that generic lisdexamfetamine was tried first, or that there's a specific clinical reason the brand is needed. See our Prior Authorization Guides for how that process typically works.

Coverage Comparison: Commercial vs. Medicare vs. Medicaid

How different coverage types handle Vyvanse and lisdexamfetamine (2026)
Coverage Type Generic Coverage Brand Coverage Common Requirement
Commercial insurance Usually preferred tier Often non-preferred; higher copay Step therapy or PA for brand
Medicare Part D Usually covered Varies by plan formulary PA common; check your Part D plan's formulary
Medicaid Usually covered for ADHD Brand rarely covered Generic-first policy in most states
Uninsured / cash-pay Full price unless using a coupon Full price, often $400+ Discount card or manufacturer program needed

Medicare coverage for Vyvanse specifically for binge eating disorder can differ from ADHD coverage. Always confirm your plan's exact formulary rules for your diagnosis rather than assuming coverage carries over.

Brand vs. Generic: Full Price Comparison

Brand Vyvanse vs. generic lisdexamfetamine (2026)
Factor Brand Vyvanse Generic Lisdexamfetamine
Cash price (30-day) $400–$558 $60–$85 with coupon
Typical annual cost, uninsured $4,800–$6,700+ $720–$1,020 with coupon
FDA-approved equivalence Reference drug Therapeutically equivalent
Insurance tier (most plans) Non-preferred or specialty Preferred
Manufacturer savings card eligible Yes, for commercially insured patients No — card applies to brand only

Vyvanse vs. Other ADHD Medications: Cost Comparison

If cost is your primary concern and your prescriber is open to alternatives, other long-acting stimulants may be significantly cheaper.

ADHD stimulant cost comparison (2026, approximate 30-day cash price)
Medication Approximate Monthly Cash Price
Generic lisdexamfetamine (Vyvanse)$60–$85 with coupon
Brand Vyvanse$400–$558
Generic mixed amphetamine salts XR (Adderall XR)$15–$50
Generic methylphenidate ER (Concerta equivalent)$20–$60

This comparison is for cost context only — switching medications is a clinical decision between you and your prescriber, not something to do based on price alone.

Ways to Save on Vyvanse

  • Ask about generic lisdexamfetamine. This is the single biggest lever — often an 80%+ reduction from brand cash price.
  • Use a free discount card. GoodRx, SingleCare, and Optum Perks coupons frequently beat insurance copays for the generic.
  • Compare pharmacies. Cash and coupon prices for the same drug and dose can vary significantly between pharmacies in the same city.
  • Ask about a 90-day supply. Mail-order or 90-day fills sometimes lower the effective monthly cost.
  • Check the Takeda savings card if you have commercial insurance and are prescribed the brand.
  • Apply to Takeda's Help at Hand program if you're uninsured or underinsured and income-eligible.
  • Compare your price against our Drug Price Checker before you fill, so you know what a fair price looks like at nearby pharmacies.

Takeda Vyvanse Savings Card: How It Works

Takeda, the manufacturer of brand Vyvanse, has offered a copay savings card for commercially insured patients. It's designed to reduce the copay for brand Vyvanse specifically — it does not apply to the generic.

Feature Detail
Who qualifies Patients with commercial (private) insurance prescribed brand Vyvanse
Who's excluded Medicare, Medicaid, and other government insurance beneficiaries, by federal anti-kickback rules
What it covers Brand Vyvanse only — not generic lisdexamfetamine
Where to enroll Through your prescriber's office or Takeda's official Vyvanse resources

Confirm current terms before assuming a specific price. Manufacturer savings card programs, eligibility rules, and maximum benefit amounts can change. If your copay for generic lisdexamfetamine is already low, the brand savings card likely won't beat it — it only applies to the brand.

Takeda Help at Hand: Free Vyvanse for Eligible Patients

For patients who are uninsured or whose insurance doesn't adequately cover the medication, Takeda's Help at Hand patient assistance program can provide brand Vyvanse — and other Takeda medications — at no cost.

Requirement What It Means
U.S. residency Must be living in the United States and prescribed by a U.S.-licensed physician
Insurance status No insurance, or insurance that doesn't adequately cover the medication
Income Household income within program limits, generally in the 250%–400% federal poverty level range depending on circumstances
Prescriber participation Your doctor's office must complete and submit the clinical section

Medicare patients: If you have Medicare and income below 150% of the federal poverty level, you're generally expected to apply for Extra Help (LIS) first. If you're denied Extra Help, you can include that denial letter with your Help at Hand application.

Income Limit Comparison for Patient Assistance

Income thresholds for manufacturer patient assistance programs are typically set as a percentage of the Federal Poverty Level (FPL) and adjusted for household size. Use this table as a general planning guide, and confirm your exact figure with the program when you apply.

Approximate income ranges by household size for manufacturer PAPs (2026)
Household Size ~250% FPL ~400% FPL
1 person~$39,000~$62,600
2 people~$52,900~$84,700
3 people~$66,800~$106,800
4 people~$80,700~$129,000

Federal poverty guidelines update annually, and exact program thresholds vary by manufacturer and sometimes by medication. Treat this table as an estimate for planning, not a guarantee of eligibility.

How to Apply: Step by Step

1

Confirm you don't have adequate coverage

Uninsured, or insured but facing an unaffordable out-of-pocket cost for Vyvanse specifically.

2

Request the Help at Hand application

Download it from Takeda's patient assistance materials, or call the program directly to have one mailed or faxed.

3

Complete the patient sections

Provide your information, household size, income, and insurance status, and sign where required.

4

Have your prescriber complete their section

Your doctor confirms the diagnosis, the medication and dose, and signs the clinical portion.

5

Attach proof of income and insurance status

A recent tax return or pay stubs, plus documentation of your insurance situation.

6

Submit by fax or mail

Your prescriber's office typically handles submission on your behalf.

Approval Timelines and Renewal

Stage Typical Timeframe
Complete first-time application2–4 weeks
Application missing documentsAdditional 2–3 weeks after resubmission
Renewal application1–3 weeks
Typical enrollment period12 months, then reapplication required

Start your renewal a few weeks before your current enrollment expires. Updated income documentation is required even if your income hasn't changed much, and a dose or medication switch generally requires a brand-new application rather than a simple renewal.

Decision Tree: What's Your Cheapest Option?

Do you have insurance?

This determines which savings tools apply to you

Yes, Insured

Ask for generic lisdexamfetamine

Usually the lowest copay on any formulary

Need brand specifically?

Try the Takeda savings card if commercially insured

No, Uninsured

Use a GoodRx/SingleCare coupon

Generic lisdexamfetamine, $60–$85/month

Income-eligible?

Apply to Takeda Help at Hand for $0 brand Vyvanse

Still too expensive?

Ask your prescriber about lower-cost stimulant alternatives

Pros and Cons of Switching to Generic

Pros

  • Often 80%+ cheaper than brand with a discount card
  • FDA-recognized as therapeutically equivalent
  • Usually placed on your insurance plan's lowest copay tier
  • Widely stocked across major pharmacy chains

Cons

  • Manufacturer savings cards for brand Vyvanse don't apply to the generic
  • Some patients report a different experience switching formulations — discuss with your prescriber
  • Generic supply can be affected by the same stimulant shortages as the brand
  • Insurance may still require prior authorization even for the generic on some plans

Common Mistakes That Cost You Money

  • □ Paying the pharmacy's default cash price without asking about a discount card.
  • □ Filling brand Vyvanse without checking if generic lisdexamfetamine is appropriate.
  • □ Assuming the Takeda savings card applies to the generic (it doesn't).
  • □ Trying to use a manufacturer copay card with Medicare or Medicaid, which isn't allowed.
  • □ Not comparing prices across nearby pharmacies before filling.
  • □ Letting Help at Hand enrollment lapse without renewing on time.

Most overpayment comes down to not asking the right question at the counter. "What's my price with a discount card, and is the generic available?" solves the majority of cases.

Real Examples: What People Actually Pay

Example 1 — Uninsured, switched to generic: A patient paying $520/month cash for brand Vyvanse asks their prescriber about generic lisdexamfetamine, then uses a SingleCare coupon. New price: $63/month — a savings of over $5,000 a year.

Example 2 — Commercial insurance, brand required: A patient's prescriber documents a clinical reason the brand is needed over generic. With commercial insurance and the Takeda savings card, the copay for brand Vyvanse drops from $110 to a lower out-of-pocket amount per fill.

Example 3 — Uninsured, income-eligible: A patient with no insurance and household income under the program threshold applies to Takeda Help at Hand with their prescriber's help. After a 3-week review, brand Vyvanse is approved at no cost, shipped through their prescriber's office.


Bottom Line

Vyvanse's price tag looks intimidating at first glance, but very few patients actually need to pay the full brand cash price. Generic lisdexamfetamine, available since August 2023, is the fastest way to cut your cost by 80% or more, and insurance, manufacturer savings cards, and income-based patient assistance cover most remaining situations.

The right move depends on your coverage: ask about the generic first, compare a discount card against your insurance copay, and if you're uninsured and income-eligible, look seriously at Takeda's Help at Hand program before accepting a full-price bill.


How We Researched This Guide

This guide was prepared by the Refill Relay Editorial Team using publicly available pharmacy pricing data, Takeda's Help at Hand program materials, FDA generic drug approval records, federal poverty level guidelines, and standard pharmacy benefit and formulary practices.

Every article undergoes editorial review for accuracy, readability, and consistency before publication. Our goal is to explain prescription pricing in clear language so patients and caregivers can find the lowest legitimate price with less friction.


References

  1. U.S. Food and Drug Administration (FDA). Generic drug approvals, lisdexamfetamine dimesylate, August 2023.
  2. Takeda Pharmaceuticals. Help at Hand Patient Assistance Program eligibility and application materials.
  3. U.S. Department of Health and Human Services. Federal Poverty Level Guidelines.
  4. Centers for Medicare & Medicaid Services (CMS). Medicare Part D formulary and coverage guidance.
  5. NeedyMeds. Independent patient assistance and discount program directory.

About Refill Relay

Refill Relay publishes evidence-based educational resources that help patients understand prescription insurance, patient assistance programs, pharmacy benefits and medication access. Our editorial team combines pricing research with practical guidance to make complex healthcare topics easier to navigate.

Editorial Standards

  • Evidence-based pricing and program research
  • Editorial review before publication
  • Regular updates when pricing or program eligibility rules change
  • Clear distinction between educational content and medical or financial advice

Related Resources

Frequently Asked Questions

Brand-name Vyvanse typically costs $400 to $558 for a 30-day supply without insurance, depending on your dose and pharmacy. Generic lisdexamfetamine is significantly cheaper, often $60 to $85 per month with a free discount card, though full retail price without a coupon can still run $300 or more.

With commercial insurance, generic lisdexamfetamine copays typically range from $10 to $35 a month on preferred tiers. Brand-name Vyvanse copays are usually higher, often $40 to $100 or more, since most formularies now place the brand on a non-preferred tier. Exact costs depend on your specific plan and deductible status.

Yes. The FDA approved the first generic lisdexamfetamine dimesylate capsules in August 2023, manufactured by several companies. The generic is considered therapeutically equivalent to brand Vyvanse and typically costs a fraction of the brand price.

Most Medicare Part D plans cover generic lisdexamfetamine for ADHD, usually requiring prior authorization or step therapy. Medicare Part D formularies vary in their coverage of brand Vyvanse specifically, and Medicare does not cover Vyvanse for binge eating disorder in the same way it does for ADHD, so always check your specific plan's formulary.

Takeda, the manufacturer of brand Vyvanse, has offered a copay savings card for eligible commercially insured patients. Availability and terms can change, so confirm current eligibility and savings amount directly through Takeda before assuming a specific price.

Help at Hand is Takeda's patient assistance program that provides brand-name Vyvanse and other Takeda medications at no cost to eligible uninsured and underinsured patients who meet income requirements, typically in the 250% to 400% federal poverty level range depending on the medication and household circumstances.

Brand Vyvanse remains expensive because it's a Schedule II controlled substance with a patented prodrug delivery system, and many insurance plans now steer members toward the lower-cost generic instead of covering the brand at a preferred rate. Once generic lisdexamfetamine launched in August 2023, its price dropped sharply compared to the brand.

Vyvanse and generic lisdexamfetamine have experienced intermittent supply shortages in 2026, similar to other prescription stimulants. Availability varies by pharmacy and dose, so it's worth calling ahead or checking multiple pharmacies before your refill is due.

No. Federal anti-kickback rules generally prohibit manufacturer copay cards for patients enrolled in Medicare, Medicaid, or other government health programs. If you have Medicare, patient assistance programs like Takeda Help at Hand or Medicare Extra Help are the relevant options instead.

Generic lisdexamfetamine is FDA-approved as therapeutically equivalent to brand Vyvanse. Most patients notice no difference, though a small number report a different experience after switching formulations. Discuss any concerns with your prescriber before or after switching.

Ask your prescriber to submit a prior authorization request, ideally documenting why generic lisdexamfetamine isn't appropriate if you need the brand. If it's still denied, you can appeal through your insurer, or explore the Takeda savings card or Help at Hand program depending on your insurance status.

Contact Refill Relay